Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002592242 | SCV003498713 | uncertain significance | X-linked severe congenital neutropenia; Thrombocytopenia 1; Wiskott-Aldrich syndrome | 2022-05-19 | criteria provided, single submitter | clinical testing | This variant, c.1197_1205dup, results in the insertion of 3 amino acid(s) of the WAS protein (p.Pro402_Pro404dup), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs781960751, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with WAS-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Mayo Clinic Laboratories, |
RCV004790375 | SCV005411430 | uncertain significance | not provided | 2024-03-18 | criteria provided, single submitter | clinical testing | BP3, PM2 |
Prevention |
RCV003420362 | SCV004107033 | uncertain significance | WAS-related disorder | 2024-04-25 | no assertion criteria provided | clinical testing | The WAS c.1197_1205dup9 variant is predicted to result in an in-frame duplication (p.Pro402_Pro404dup). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0053% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |